Hyperfine, Inc. (HYPR) DCF Valuation

Valoración de DCF de Hyperfine, Inc. (Hypr)

US | Healthcare | Medical - Devices | NASDAQ
Hyperfine, Inc. (HYPR) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Hyperfine, Inc. (HYPR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus opciones de inversión con la calculadora DCF de Hyperfine, Inc. (HYPR)! Explore las finanzas hiperfinas reales, ajuste las proyecciones y gastos de crecimiento, y observe cómo estas modificaciones afectan el valor intrínseco de Hyperfine, Inc. (HYPR) en tiempo real.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .3 1.5 6.8 11.0 18.3 30.2 50.0 82.7 136.9
Revenue Growth, % 0 0 408.84 355.48 61.9 65.48 65.48 65.48 65.48 65.48
EBITDA -19.8 -23.2 -64.1 -72.9 -47.1 -11.0 -18.1 -30.0 -49.6 -82.1
EBITDA, % 100 -7891.84 -4287.57 -1069.25 -426.59 -60 -60 -60 -60 -60
Depreciation .1 .3 .7 1.0 1.1 9.9 16.4 27.1 44.9 74.3
Depreciation, % 100 98.3 48.53 14.9 9.55 54.26 54.26 54.26 54.26 54.26
EBIT -20.0 -23.5 -64.9 -73.9 -48.1 -11.0 -18.1 -30.0 -49.6 -82.1
EBIT, % 100 -7990.14 -4336.1 -1084.15 -436.14 -60 -60 -60 -60 -60
Total Cash 26.4 62.7 188.5 117.5 75.2 18.3 30.2 50.0 82.7 136.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .6 2.6 4.1
Account Receivables, % 100 59.18 43.05 37.53 37.45
Inventories .0 1.7 4.3 4.6 6.6 15.6 25.8 42.7 70.7 117.0
Inventories, % 100 584.35 288.1 67.83 59.66 85.5 85.5 85.5 85.5 85.5
Accounts Payable 1.2 .9 2.2 .7 1.2 11.7 19.4 32.1 53.1 87.9
Accounts Payable, % 100 322.45 150.27 9.95 11 64.19 64.19 64.19 64.19 64.19
Capital Expenditure -.2 -1.6 -2.7 -.6 -.8 -7.9 -13.0 -21.6 -35.7 -59.1
Capital Expenditure, % 100 -533.33 -181.22 -8.59 -7.29 -43.17 -43.17 -43.17 -43.17 -43.17
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -19.3 -23.4 -64.8 -73.2 -48.1 -10.9 -18.0 -29.7 -49.2 -81.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -18.2 -26.8 -68.6 -76.5 -50.9 -13.3 -23.8 -39.4 -65.1 -107.8
WACC, % 8.42 8.42 8.42 8.42 8.42 8.42 8.42 8.42 8.42 8.42
PV UFCF
SUM PV UFCF -182.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -110
Terminal Value -1,712
Present Terminal Value -1,143
Enterprise Value -1,325
Net Debt -75
Equity Value -1,250
Diluted Shares Outstanding, MM 71
Equity Value Per Share -17.53

What You Will Get

  • Real HYPR Financial Data: Pre-filled with Hyperfine’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Hyperfine’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Financial Inputs: Adjust essential variables such as revenue projections, profit margins, and investment costs.
  • Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and additional financial metrics.
  • High-Precision Accuracy: Leverages Hyperfine's actual financial data for precise valuation results.
  • Effortless Scenario Testing: Easily explore various assumptions and analyze different outcomes.
  • Efficiency Booster: Streamline your workflow by avoiding the complexities of creating detailed valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Hyperfine, Inc. (HYPR) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Hyperfine, Inc. (HYPR)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and industry consultants.
  • Accurate Data: Hyperfine, Inc.’s (HYPR) historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Clear, step-by-step instructions help you navigate the process with ease.

Who Should Use Hyperfine, Inc. (HYPR)?

  • Healthcare Professionals: Leverage advanced imaging technology to enhance patient care.
  • Medical Researchers: Utilize innovative tools for groundbreaking studies and trials.
  • Investors: Analyze market potential and growth opportunities in the healthcare sector.
  • Educators and Students: Explore practical applications of medical imaging in academic settings.
  • Regulatory Bodies: Ensure compliance and safety standards in medical technology.

What the Template Contains

  • Pre-Filled DCF Model: Hyperfine, Inc.’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Hyperfine, Inc.’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.